Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2017
18th World Conference on Lung Cancer
Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan
Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2324
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
WS 01 - IASLC Supporting the Implementation of Quality Assured Global CT Screening Workshop (By Invitation Only) (ID 632)
- Type: Workshop
- Track: Radiology/Staging/Screening
- Presentations: 44
- Moderators:
- Coordinates: 10/14/2017, 08:30 AM - 09:00 PM, F203 (Annex Hall)
-
+
WS 01.01 - Welcome and Aims of Workshop (ID 10613)
08:30 - 08:40 AM | Presenting Author(s): John Kirkpatrick Field, James L Mulshine
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.02 - Session 1 (ID 10640)
08:40 - 08:40 AM | Presenting Author(s): John Kirkpatrick Field, Harry J De Koning
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.03 - CT Screened Lung Cancer Survivor: A Patients Prospective on Lung Cancer Screening (ID 10641)
08:40 - 08:55 AM | Presenting Author(s): Andrea Katalin Borondy Kitts
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.04 - Tobacco Cessation in the CT Screening Setting – Is It Working? (ID 10642)
08:55 - 09:10 AM | Presenting Author(s): Jamie Ostroff
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.05 - How Do We Engage the High Risk Population in Lung Cancer Screening? - Primary Care Perspective in UK (ID 10643)
09:10 - 09:17 AM | Presenting Author(s): Martin Ledson
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.06 - How Do We Engage the High Risk Population in Lung Cancer Screening? - Strategy for Engaging Participants (ID 10644)
09:17 - 09:25 AM | Presenting Author(s): Angela Meredith Criswell
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.07 - Modeling Smoking Trends and CT Screening to 2060 (ID 10645)
09:25 - 09:40 AM | Presenting Author(s): Rafael Meza | Author(s): J. Jeon
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.08 - Discussion (ID 10646)
09:40 - 09:50 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.09 - Session 2: Radiological Imaging – Quality Assurance and Training (ID 10647)
09:50 - 09:50 AM | Presenting Author(s): David Raymond Baldwin, Matthijs Oudkerk, Ning Wu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.10 - Reviews of International Guidelines for Management of Pulmonary Nodules (i.e. NCCN/ LUNG-RADS, BTS, Fleischner IELCAP, etc.) (ID 10648)
09:50 - 10:05 AM | Presenting Author(s): David F Yankelevitz
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.11 - Planning for European Registries for CT Screened Images – What Are Their Objectives? (ID 10649)
10:05 - 10:20 AM | Presenting Author(s): Matthijs Oudkerk | Author(s): M.A. Heuvelmans
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.12 - Planning for USA Registries for CT Screened Images – What Are Their Objectives? (ID 10650)
10:20 - 10:35 AM | Presenting Author(s): Ricardo S Avila | Author(s): Claudia I Henschke, David F Yankelevitz
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.13 - Next Generation CT Scanners for Lung Cancer Screening – Way Forward (ID 10651)
10:35 - 10:50 AM | Presenting Author(s): Sebastian Schmidt
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.14 - Discussion (ID 10652)
10:50 - 11:00 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.15 - Tea/Coffee Break (ID 10653)
11:00 - 11:30 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.16 - Session 3: Added Value to Lung Cancer CT Screening Programs (ID 10654)
11:30 - 11:30 AM | Presenting Author(s): Kwun M Fong, Nir Peled
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.17 - The Potential of Radio-omics and Deep Learning (ID 10655)
11:30 - 11:45 AM | Presenting Author(s): Anthony Reeves
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.18 - Lung Cancer Indicator Detection Trial (LuCID) (ID 10656)
11:45 - 12:00 PM | Presenting Author(s): Marc Phillipe Van Der Schee | Author(s): J. Dickson, M. Ruparel, Sam M Janes, S. Dragonieri, H. Wirtz, L. Fuller, S. Grundy, David Raymond Baldwin, P. Crosbie, A. Prasad, M. Haris, A. Barlow, L. Calvert, A. Wight, J. Bennett, M. Gaga, S. Chee, V. Conteh, Martin Ledson, C. Hodkinson, J. Boschmans, R. Smith, R. Parris, D. Apthorp, S. Kitchen, M. Allsworth, B. Boyle, Robert Campbell Rintoul
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.19 - Cardiologists View of Utilising Calcium Scoring in Lung Cancer Screening Trials (ID 10657)
12:00 - 12:15 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.20 - Lunch (ID 10658)
12:15 - 01:35 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.21 - Session 4: The Concept of Collaboration in CT Screening Programs (ID 10659)
01:35 - 01:35 PM | Presenting Author(s): David F Yankelevitz, Angela Meredith Criswell
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.22 - Quality Control Throughout Lung Cancer Management (ID 10662)
01:35 - 01:43 PM | Presenting Author(s): David Gierada
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.23 - Radiology Leading But Integrated? (ID 10664)
01:43 - 01:51 PM | Presenting Author(s): David F Yankelevitz
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.24 - Designs of Possible Biomarkers for Future Screening Programs? (ID 10665)
01:51 - 01:59 PM | Presenting Author(s): John Kirkpatrick Field | Author(s): M.P. Davies
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.25 - Smoking Cessation – How to Integrate? (ID 10670)
01:59 - 02:07 PM | Presenting Author(s): Jamie Ostroff
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.26 - COPD Integration into CT Screening – Patient Benefit? (ID 10671)
02:07 - 02:15 PM | Presenting Author(s): Javier J. Zulueta
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.27 - Surgical Integration at the Earliest Stages Planned CT Screening? (ID 10672)
02:15 - 02:23 PM | Presenting Author(s): Jesper Holst Pedersen
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.28 - Discussion (ID 10673)
02:23 - 02:40 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.29 - Session 5: The Current Global Implementation of CT Lung Cancer Screening Programs (ID 10674)
02:40 - 02:40 PM | Presenting Author(s): Shuji Sakai, Robert Smith
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.30 - China (ID 10675)
02:40 - 02:50 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.31 - Japan (ID 10676)
02:50 - 03:00 PM | Presenting Author(s): Kazuto Ashizawa
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.32 - Canada & Australia (ID 10677)
03:00 - 03:20 PM | Presenting Author(s): Kwun M Fong
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.33 - EU Commission Recommendations on Screening (ID 10678)
03:20 - 03:30 PM | Presenting Author(s): Denis Horgan
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.34 - CT Screening in USA – Current Issues around Implementation – Lessons to be Learnt (ID 10679)
03:30 - 03:40 PM | Presenting Author(s): James L Mulshine
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.35 - USA Roundtable Update (ID 10680)
03:40 - 03:50 PM | Presenting Author(s): Ella Kazerooni
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.36 - NELSON – Update (ID 10681)
03:50 - 04:00 PM | Presenting Author(s): Harry J De Koning
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.37 - Tea/Coffee Break (ID 10682)
04:00 - 04:20 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.38 - Session 6: What Priorities and Recommendations Should the IASLC Executive Focus On: How They Can Support Leadership in this Area of Lung Cancer (Round Table Discussion) (ID 10683)
04:20 - 06:00 PM | Presenting Author(s): John Kirkpatrick Field, James L Mulshine
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.39 - 1. How Do We Ensure Smoking Cessation is Integrated into Best Practice Screening? (ID 10684)
06:00 - 06:00 PM | Presenting Author(s): Angela Meredith Criswell
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.40 - 2. How Do We Optimise an International Approach to Pulmonary Nodules Management? (ID 10685)
06:00 - 06:00 PM | Presenting Author(s): Matthijs Oudkerk
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.41 - 3. How to Talk About Lung Cancer Screening Which is More Appropriate to the Public? (ID 10686)
06:00 - 06:00 PM | Presenting Author(s): Sam M Janes
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.42 - 4. Can we Implement International Standards for Quantitative CT Imaging within Lung Cancer? (ID 10687)
06:00 - 06:00 PM | Presenting Author(s): David F Yankelevitz
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.43 - 5. How Can IASLC Lead Global Lung Cancer Progress Over the Next 10 Years? (ID 10688)
06:00 - 06:00 PM | Presenting Author(s): Kwun M Fong
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 01.44 - Networking Dinner (ID 10689)
06:00 - 09:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02 - IASLC Symposium on the Advances in Lung Cancer CT Screening (Ticketed Session) (ID 631)
- Type: Symposium
- Track: Radiology/Staging/Screening
- Presentations: 21
- Moderators:
- Coordinates: 10/14/2017, 09:00 AM - 06:15 PM, F201 + F202 (Annex Hall)
-
+
WS 02.01 - Welcome to the Special Symposium (ID 10583)
09:00 - 09:10 AM | Presenting Author(s): Claudia I Henschke, Giulia Veronesi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.02 - Session 1: Status of Lung Cancer Screening in USA and Europe (ID 10584)
09:10 - 09:10 AM | Presenting Author(s): Giulia Veronesi, Robert Smith
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.03 - Lung Cancer Screening – IELCAP Contribution to CT Screening Implementation (ID 10620)
09:10 - 10:10 AM | Presenting Author(s): Claudia I Henschke | Author(s): Anthony Reeves, David F Yankelevitz
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.04 - Lung Cancer Screening Status in Europe (ID 10621)
10:10 - 10:40 AM | Presenting Author(s): Giulia Veronesi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.05 - The European Commission Recommendations on Lung Cancer Screening (ID 10622)
10:40 - 11:00 AM | Presenting Author(s): Denis Horgan
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.06 - Group Discussion (ID 10623)
11:00 - 11:30 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.07 - Tea/Coffee Break (ID 10585)
11:30 - 12:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.08 - Session 2: Current Lung Cancer Screening Guidelines (Panel Discussion) (ID 10586)
12:00 - 12:00 PM | Presenting Author(s): Claudia I Henschke, Javier J. Zulueta
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.09 - Lung Cancer Guidelines (ID 10624)
12:00 - 01:00 PM | Presenting Author(s): Matthew Eric Callister, Stephen Lam, Sadayuki Murayama, John Kirkpatrick Field, David F Yankelevitz, Nasser Altorki
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.10 - Lunch (ID 10587)
01:00 - 02:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.11 - Session 3: Early Detection Biomarkers (ID 10588)
02:00 - 02:00 PM | Presenting Author(s): Luis M Montuenga, Nir Peled
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.12 - Lung Cancer Biomarkers - Do We Have Good Candidates for Early Detection? (ID 10625)
02:00 - 02:30 PM | Presenting Author(s): Pierre P Massion
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.13 - New Approaches to Interventional Pulmonology for Lung Cancer Screening (ID 10626)
02:30 - 03:00 PM | Presenting Author(s): Nir Peled
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.14 - The Airway Transcriptome (ID 10627)
03:00 - 03:30 PM | Presenting Author(s): Avrum Spira
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.15 - Quality Control for Lung Imaging Biomarkers (ID 10628)
03:30 - 04:00 PM | Presenting Author(s): Ricardo S Avila | Author(s): Claudia I Henschke, David F Yankelevitz
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.16 - Tea/Coffee Break (ID 10589)
04:00 - 04:15 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.17 - Session 4: Lung Cancer Screening’s Impact on COPD and Smoking Cessation (ID 10590)
04:15 - 04:15 PM | Presenting Author(s): Andrea Katalin Borondy Kitts, Kazuto Ashizawa
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.18 - Lung Cancer Screening and COPD – A Pneumologist’s Viewpoint (ID 10629)
04:15 - 04:45 PM | Presenting Author(s): Javier J. Zulueta
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.19 - Tobacco Cessation in the CT Screening Setting – The Way Forward? (ID 10630)
04:45 - 05:15 PM | Presenting Author(s): Jamie Ostroff
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.20 - Communicating Complex Issues Simply: Pivotal Role of Nursing in Lung Cancer Screening (ID 10631)
05:15 - 06:00 PM | Presenting Author(s): Joelle Thirsk Fathi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 02.21 - Final Discussion (ID 10632)
06:00 - 06:15 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West (ID 630)
- Type: Joint Session IASLC/CSCO/CAALC
- Track: Immunology and Immunotherapy
- Presentations: 28
- Moderators:C. Bai, Fred R. Hirsch, Tony SK Mok, Yi-Long Wu
- Coordinates: 10/15/2017, 07:30 AM - 11:30 AM, F203 (Annex Hall)
-
+
JCSE 01.01 - Breakfast and Poster Viewing (ID 8221)
07:30 - 07:55 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.02 - Welcome and Introduction (ID 8222)
07:55 - 08:00 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.03 - The Science of Immunotherapy (ID 8220)
08:00 - 08:20 AM | Presenting Author(s): Roy S. Herbst
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.05 - PD-1+CD8+ T and iNKT Cell Based Immunotherapy on Lung Cancer (ID 8224)
08:20 - 08:40 AM | Presenting Author(s): Jianqing Xu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.06 - ctDNA Based Tumor Mutation Burden Evaluation for Predicting Immunotherapy Effect (ID 8225)
08:40 - 09:00 AM | Presenting Author(s): Jie Hu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.07 - Ongoing Trials in China on Checkpoint Inhibitors and Other Immunotherapies (ID 8226)
09:00 - 09:20 AM | Presenting Author(s): Qing Zhou
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.08 - Coffee Break and Poster Viewing (ID 8227)
09:20 - 09:45 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.09 - Therapeutic Practices in Europe for Immunotherapy, including Biomarkers (ID 8228)
09:45 - 10:05 AM | Presenting Author(s): Solange Peters
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.10 - The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer (ID 10904)
10:05 - 10:20 AM | Presenting Author(s): Songtao Xu | Author(s): W. Zhong, Y. Zhang, W. Mao, L. Wu, Y. Shen, Y. Liu, C. Chen, Y. Cheng, L. Xu, J. Wang, K. Fei, X. Li, J. Li, C. Huang, Z. Liu, S. Xu, K. Chen, S. Xu, L. Liu, P. Yu, B. Wang, H. Ma, H. Yan, X. Yang, Yi-Long Wu, Q. Wang
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.11 - A Multicenter, Non-Interventional Study on Real World EGFR Testing and in Patients with IIIB/IV NSCLC in Northern China (ID 10905)
10:20 - 10:35 AM | Presenting Author(s): Ying Cheng | Author(s): Y. Wang, J. Zhao, Y. Liu, H. Gao, K. Ma, S. Zhang, H. Xin, J. Liu, H. Chengbo, Z. Zhu, Y. Wang, J. Chen, F. Wen, J. Li, Z. Jie, Z. Zheng, Z. Dai, H. Piao, X. Li, Y. Li, M. Zhong, R. Ma, Y. Zhuang, Y. Xu, Z. Qu, H. Yang, C. Pan, F. Yang, D. Zhang, B. Li
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.13 - Discussant Oral Abstracts - JCSE 01.10, JCSE 01.11, JCSE 01.12 (ID 10909)
10:50 - 11:10 AM | Presenting Author(s): Joel W. Neal
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.14 - Discussant Poster Abstracts (ID 10908)
11:10 - 11:30 AM | Presenting Author(s): Bob T. Li, Jonathan W Riess
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.19 - EGFR Mutation Correlates with Uninflamed Phenotype and Weak Immunogenicity, Causing Impaired Response to PD-1 Blockade in NSCLC (ID 10915)
11:30 - 11:30 AM | Presenting Author(s): Zhong-Yi Dong | Author(s): W. Zhong, Yi-Long Wu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.21 - Combination of Biomarker and Clinicopathologic Characters May Circle out Beneficiaries through Second-Line Immunotherapy: A Meta Analyse (ID 10917)
11:30 - 11:30 AM | Presenting Author(s): Si-Yang Liu | Author(s): Z. Dong, C. Zhang, W. Zhong, Yi-Long Wu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.23 - The Feasibility of Osimertinib Treatment on Brain Metastases in NSCLC Patients After 1st Generation EGFR-TKI Resistance: A Preliminary Study (ID 10919)
11:30 - 11:30 AM | Presenting Author(s): Lucheng Zhu | Author(s): S. Zhang, B. Xia, X. Chen, S. Ma
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.24 - Detection of EGFR, ALK and Other Driver Oncogenes from Plasma cfDNA by Single Molecule Amplification and Re-sequencing Technology (cSMART) (ID 10920)
11:30 - 11:30 AM | Presenting Author(s): Tony SK Mok | Author(s): Shun Lu, Y. Cheng, Jie Wang, Y. Wang, T. Wang, T. Yung, X. Su, F. Sun, F. Sun, L.T. Wang, Yi-Long Wu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.25 - Detection of EGFR T790M Mutations by Four Testing Platforms in ctDNA from Chinese Patients with Advanced NSCLC (ID 10921)
11:30 - 11:30 AM | Presenting Author(s): Xu-Chao Zhang | Author(s): Z. Liang, Y. Chen, H. Zhang, W. Gang, Y. Lu, Z. Liang, Y. Cheng, Y. Hu, Jie Wang, J. Ying, W. Liu, Yi-Long Wu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.26 - Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC (ID 10922)
11:30 - 11:30 AM | Presenting Author(s): Yangsi Li | Author(s): B. Jiang, Jin -Ji Yang, X. Zhang, Z. Zhang, Qing Zhou, H. Tu, Z. Wang, H. Chen, C. Xu, B. Wang, Yi-Long Wu
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.27 - Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial (ID 10923)
11:30 - 11:30 AM | Presenting Author(s): Tony SK Mok | Author(s): Solange Peters, D. Ross Camidge, Shirish M Gadgeel, S.I. Ou, D. Kim, Rafal Dziadziuszko, F. De Marinis, R. Sangha, A. Zeaiter, J. Noe, E. Nueesch, T. Liu, I. Loftin, C. Williams, Alice Shaw
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.28 - NGS Sequencing Based Liquid / Tissue Biopsy Identified Coexistence of HER2 Amplification and Mutation in Advanced NSCLC Patients (ID 10924)
11:30 - 11:30 AM | Presenting Author(s): Rongrong Chen | Author(s): J. Zhao, G. Lin, L. Liu, L. Chen, X. Hu, X. Ai, Z. Fan, C. Xu, W. Wang, W. Zhuang, M. Fang, Y. Zhu, G. Chen, Y. Guan, L. Yang, X. Xia, X. Yi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
JCSE 01.29 - Closing Remarks (ID 8230)
11:30 - 11:30 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01 - Young Investigator and First Time Attendee Session (ID 588)
- Type: Young Investigator
- Track: Education/Publication/Career Development
- Presentations: 14
- Moderators:Peter Goldstraw, Giorgio Vittorio Scagliotti
- Coordinates: 10/15/2017, 08:00 AM - 11:30 AM, F201 + F202 (Annex Hall)
-
+
YI 01.01 - Introduction to IASLC: What It Can Do For You (ID 7845)
08:00 - 08:10 AM | Presenting Author(s): Silvia Novello
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.02 - Planning an Academic Career in Lung Cancer (ID 7846)
08:10 - 08:25 AM | Presenting Author(s): Navneet Singh
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.03 - Community versus Academic Oncology (ID 7847)
08:25 - 08:40 AM | Presenting Author(s): Philip Bonomi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.04 - Clinical Trials 101 (ID 7848)
08:40 - 08:55 AM | Presenting Author(s): Julie R Brahmer
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.05 - Investigator Initiated Trials (ID 7849)
08:55 - 09:10 AM | Presenting Author(s): Daniel SW Tan
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.06 - Coffee Break (ID 8130)
09:10 - 09:40 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.07 - How to Get Your Paper Published (ID 7850)
09:40 - 09:55 AM | Presenting Author(s): Alex Adjei
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.08 - Why Should I Publish? An Overview of the Manuscript Cycle: From Submission to Publication (ID 7851)
09:55 - 10:10 AM | Presenting Author(s): Jim Jett
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.09 - How to Prepare an Abstract for an International Conference and How to Prepare Your Presentation for the Conference (Tips and Tricks) (ID 7852)
10:10 - 10:25 AM | Presenting Author(s): Michael Boyer
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.10 - How to Write a Grant Application for Young Investigators (ID 7853)
10:25 - 10:40 AM | Presenting Author(s): Heather A Wakelee
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.11 - The Young Investigator Travel Award Experience - A Report from a Previous Award Winner (ID 7854)
10:40 - 10:45 AM | Presenting Author(s): Takahiro Karasaki
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.12 - Making the Most of the WCLC: A Guide for First Time Attendee - From an Expert Perspective (ID 7855)
10:45 - 11:00 AM | Presenting Author(s): Suresh Senan
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.13 - Making the Most of the WCLC: A Guide for First Time Attendee - From a Second Time Attendee (ID 7856)
11:00 - 11:05 AM | Presenting Author(s): Deepali Jain
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
YI 01.14 - Q&A (ID 11027)
11:05 - 11:30 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01 - Supporting the Clinical Management of Lung Cancer Patients through Innovation in Diagnostics - Roche (ID 761)
- Type: Workshop
- Track: Radiology/Staging/Screening
- Presentations: 10
- Moderators:
- Coordinates: 10/15/2017, 08:15 AM - 12:00 PM, Room 315
-
+
SS 01.01 - Welcome & Opening (ID 10968)
08:15 - 08:30 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.02 - Unmet Medical Needs and Challenges in Lung Cancer Patient Management - A Pulmonologists Perspective (ID 10969)
08:30 - 08:47 AM | Presenting Author(s): Ramon Marrades
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.03 - Protein-based Biomarkers as Tools to Support Clinical Decision Making with Results from the Laboratory (ID 10970)
08:47 - 09:05 AM | Presenting Author(s): Rafael Molina
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.04 - Panel - Q&A (ID 10971)
09:05 - 09:20 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.05 - Break (ID 10972)
09:20 - 09:35 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.06 - Integrated Tissue and Molecular Diagnostics for Optimal Lung Cancer Patient Care (ID 10973)
09:35 - 10:10 AM | Presenting Author(s): Stephen P Finn
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.07 - The Evolution of Lung Cancer Treatment - Clinical Impact of Genomic Alterations Detected in Tissue and Plasma (ID 10974)
10:10 - 10:45 AM | Presenting Author(s): Alice Shaw
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.08 - Clinical Utility of Liquid Biopsy in Managing NSCLC Patients - Performance and Impact on Clinical Decisions (ID 10975)
10:45 - 11:20 AM | Presenting Author(s): Shobhit Baijal
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.09 - Panel - Q&A (ID 10976)
11:20 - 11:50 AM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
SS 01.10 - Wrap-up & Closing (ID 10977)
11:50 - 12:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 01 - Treatment Options for Patients with ALK+ NSCLC: How is the Paradigm Changing? - Takeda Oncology (ID 634)
- Type: Industry Supported Symposium
- Track: ISS
- Presentations: 6
- Moderators:Tony SK Mok, D. Ross Camidge
- Coordinates: 10/15/2017, 11:30 AM - 01:00 PM, Room 303 + 304
-
+
ISS 01.01 - Welcome and Introduction (ID 10615)
11:30 - 11:35 AM | Presenting Author(s): Tony SK Mok, D. Ross Camidge
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 01.02 - Long-term Survival for Patients with ALK+ NSCLC: An Achievable Aim? (ID 10617)
11:35 - 11:55 AM | Presenting Author(s): Tony SK Mok
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 01.03 - Treating Patients with ALK+ NSCLC: What Are the Unmet Needs? (ID 10616)
11:55 - 12:15 PM | Presenting Author(s): D. Ross Camidge
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 01.04 - Testing Resistant ALK+ NSCLC: Can Treatment Be Personalised? (ID 10618)
12:15 - 12:35 PM | Presenting Author(s): Maurice Pérol
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 01.05 - Panel Discussion and Questions from the Audience (ID 10963)
12:35 - 12:50 PM | Presenting Author(s): Tony SK Mok, D. Ross Camidge, Maurice Pérol
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 01.06 - Summary and Conclusions (ID 10619)
12:50 - 01:00 PM | Presenting Author(s): Tony SK Mok, D. Ross Camidge
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03 - ITONF Lung Cancer and Mesothelioma Workshop (Ticketed Session) (ID 751)
- Type: Workshop
- Track: Mesothelioma
- Presentations: 19
- Invitation / Session Details: Click here to view PDF
- Moderators:
- Coordinates: 10/15/2017, 12:15 PM - 05:55 PM, Room 313
-
+
WS 03.01 - ITONF Members Meeting (with Lunch) (ID 10881)
12:15 - 01:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.02 - Local Therapies for Lung Cancer and Mesothelioma (ID 10946)
01:00 - 01:00 PM | Presenting Author(s): Caitlin Broderick
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.03 - Welcome Address (ID 10882)
01:00 - 01:05 PM | Presenting Author(s): Beth Ivimey
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.04 - The Oncology Nurse Role in the Treatment of Lung Cancer and Mesothelioma: The Recent Practice in Japan (ID 10883)
01:05 - 01:30 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.05 - Explaining Radiation Treatments in Lung Cancer (ID 10884)
01:30 - 01:50 PM | Presenting Author(s): Mary Duffy
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.06 - Local Treatments for Lung Cancer – Blade vs Beam: A Debate (ID 10885)
01:50 - 02:20 PM | Presenting Author(s): David L Ball, Melissa Culligan
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.07 - Wellness and Supportive Care for Lung Cancer and Mesothelioma Patients (ID 10947)
02:20 - 02:20 PM | Presenting Author(s): Kathleen Ann Gamblin
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.08 - Acute Thoracic Oncology Nursing (ID 10887)
02:20 - 02:40 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.09 - Living Well with Lung Cancer and Mesothelioma (ID 10888)
02:40 - 03:00 PM | Presenting Author(s): Pippa Labuc
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.10 - Panel Discussion (ID 10889)
03:00 - 03:10 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.11 - Break (ID 10890)
03:10 - 03:25 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.12 - Systemic Treatments for Lung Cancer and Mesothelioma (ID 10948)
03:25 - 03:25 PM | Presenting Author(s): Massey Nematollahi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.13 - Targeted Therapies: Toxicities Management and Care (ID 10891)
03:25 - 03:50 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.14 - Targeted Therapies: Case Studies and Experience from Different Regions Q&A (ID 10892)
03:50 - 04:15 PM | Presenting Author(s): Beth Ivimey, Caitlin Broderick, Beth Eaby-Sandy, John McPhelim
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.15 - Immuno-oncology Overview (ID 10893)
04:15 - 04:35 PM | Presenting Author(s): Marianne Davies
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.16 - Japan’s Challenges in Immunotherapy for Lung Cancer as a Pioneer: The Nurses View (ID 10894)
04:35 - 04:55 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.17 - Latest Advances in the Treatment of Malignant Pleural Mesothelioma (ID 10895)
04:55 - 05:20 PM | Presenting Author(s): Mary Hesdorffer
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.18 - Mesothelioma Online Educational Programs, ITONF Nurse Education Programs & N&AH Immunotherapy Guidelines Launch (ID 10896)
05:20 - 05:55 PM | Presenting Author(s): Melissa Culligan, Liz Darlison, Anne Fraser, Kathleen Ann Gamblin
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 03.19 - Close (ID 10886)
05:55 - 05:55 PM | Presenting Author(s): Melissa Culligan
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04 - Minimally Invasive Diagnosis and Staging of Lung Cancer – Interventional Pulmonology Hands-On Workshop (Ticketed Session) (ID 766)
- Type: Workshop
- Track: Pulmonology/Endoscopy
- Presentations: 11
- Moderators:
- Coordinates: 10/15/2017, 01:00 PM - 05:00 PM, Room 416 + 417
-
+
WS 04.01 - Welcome and Introduction (ID 11036)
01:00 - 01:10 PM | Presenting Author(s): Kazuhiro Yasufuku
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.02 - EBUS-TBNA – Role in Invasive Mediastinal Staging (ID 11037)
01:10 - 01:30 PM | Presenting Author(s): Kazuhiro Yasufuku
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.03 - Specimen Acquisition and Processing (ID 11038)
01:30 - 01:50 PM | Presenting Author(s): Takahiro Nakajima
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.04 - Radial Probe EBUS – Methods and Results (ID 11039)
01:50 - 02:10 PM | Presenting Author(s): Takehiro Izumo
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.05 - Navigational Bronchoscopy (ID 11040)
02:10 - 02:30 PM | Presenting Author(s): L. Donahoe
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.06 - Hands-On Session (5 work stations) (ID 11041)
02:30 - 05:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.07 - 1. EBUS-TBNA (ID 11042)
05:00 - 05:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.08 - 2. Radial Probe EBUS (ID 11043)
05:00 - 05:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.09 - 3. Specimen Handling (ID 11044)
05:00 - 05:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.10 - 4. Navigational Bronchoscopy (Super Dimension) (ID 11045)
05:00 - 05:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
WS 04.11 - 5. Navigational Bronchoscopy (BF Navi) (ID 11046)
05:00 - 05:00 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 02 - Treatment Selection Strategies in Advanced NSCLC – Implications and Global Perspectives - Lilly Oncology (ID 635)
- Type: Industry Supported Symposium
- Track: ISS
- Presentations: 7
- Moderators:N. Thatcher, Kazuhiko Nakagawa
- Coordinates: 10/15/2017, 03:00 PM - 04:30 PM, Room 303 + 304
-
+
ISS 02.01 - Welcome & Introduction (ID 10633)
03:00 - 03:05 PM | Presenting Author(s): N. Thatcher, Kazuhiko Nakagawa
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 02.02 - Increasing Complexity of Therapeutic Decision-Making for Advanced NSCLC (ID 10634)
03:05 - 03:25 PM | Presenting Author(s): David R. Gandara
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 02.03 - How Long Do I Treat? When to Stop? Implications for Clinical Practice (ID 10635)
03:25 - 03:40 PM | Presenting Author(s): Silvia Novello
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 02.04 - Illustrative and Interactive Case Study Discussions (ID 10636)
03:40 - 04:10 PM | Presenting Author(s): Oscar Arrieta, Myung-Ju Ahn, Hidehito Horinouchi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 02.05 - Global Perspectives on the Changing Treatment Paradigm in Advanced NSCLC (ID 10637)
04:10 - 04:20 PM | Presenting Author(s): James Chih-Hsin Yang
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 02.06 - Panel Discussion (ID 10638)
04:20 - 04:30 PM | Presenting Author(s): N. Thatcher, Kazuhiko Nakagawa
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 02.07 - Symposium Closes (ID 10639)
04:30 - 04:30 PM
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03 - Management of Advanced NSCLC: Where Do Immune Checkpoint Inhibitors Fit In? - Medscape - Supported by Independent Educational Grant from AstraZeneca Pharmaceuticals LP (ID 636)
- Type: Industry Supported Symposium
- Track: ISS
- Presentations: 8
- Moderators:Hossein Borghaei
- Coordinates: 10/15/2017, 04:45 PM - 06:15 PM, Room 301 + 302
-
+
ISS 03.01 - Welcome and Introductions (ID 10690)
04:45 - 04:50 PM | Presenting Author(s): Hossein Borghaei
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03.02 - Where Do Checkpoint Inhibitors Fit in Second-Line Therapy? (ID 10691)
04:50 - 05:05 PM | Presenting Author(s): Fabrice Barlesi
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03.03 - Where Do Checkpoint Inhibitors Fit in First-Line Therapy? (ID 10692)
05:05 - 05:20 PM | Presenting Author(s): Edward Brian Garon
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03.04 - The Immune Effects of Immune Checkpoint Inhibitors: ir-AEs (ID 10693)
05:20 - 05:35 PM | Presenting Author(s): Hossein Borghaei
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03.05 - Double, Double, Toil and Trouble With Combination Therapy? (ID 10694)
05:35 - 05:50 PM | Presenting Author(s): Edward Brian Garon
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03.06 - The Future of Checkpoint Inhibitors in Your Practice (ID 10695)
05:50 - 06:00 PM | Presenting Author(s): Hossein Borghaei
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03.07 - Concluding Remarks (ID 10696)
06:00 - 06:05 PM | Presenting Author(s): Hossein Borghaei
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
-
+
ISS 03.08 - Question and Answer Session (ID 10697)
06:05 - 06:15 PM | Presenting Author(s): Hossein Borghaei, Fabrice Barlesi, Edward Brian Garon
- Abstract
The abstract for this presentation will be made available after embargo. Please return after this date to review
